Autoplay
Just videos
×
- Save Post
Save this post - Not Interested
Never show me again - Copy Link
Copy to clipboard
See more item(s)
-
- Related Posts
- You may like
- Politics
- Arabian Music
- Shinto
- Shopping
- Sports
- Entertainment
- Discovery
- Islam
- Creative
- European Movies & TV Programmes
- African Movies & TV Programmes
- Travel
- European Music
- Education
- Jainism
- General Music
- Christianity
- Asian Music
- Kids 5 years to 8 years
- Podcast
- Architecture
- Technology
- Comedy
- Decor
- Others
- Religion
- Self discovery
- Bahai Faith
- Kids 4 years and under
- Kids TV and Animation
- General TV & Movie
- Self motivation
- Taoism
- Kids 9 years to 12 years
- Asian Movies & TV Programmes
- News
- Confucianism
- Arabian Movies & TV Programmes
- Judaism
- Games
- Sikhism
- Animals
- Cookery
- DIY
- Beauty
- Nature
- Style
- Buddhism
- Art
- Hinduism
-
Artificial Intelligence in Oncology market Growth Opportunity and Industry Forecast to 2035
The “Artificial Intelligence in Oncology Market, 2022-2035” report features an extensive study on the current and future potential of AI.
Key Market Insights
A detailed overview of the overall market landscape of players engaged in the development of artificial intelligence in oncology- based software solutions.
Elaborate profiles of prominent players that specialize in offering artificial intelligence in oncology- based software solutions.
A competitiveness analysis of artificial intelligence in oncology- based software providers, based on supplier strength, portfolio diversity and portfolio strength.
An in-depth analysis of patents related to artificial intelligence in oncology- based software solutions, filed / granted till date.
An analysis of the partnerships that have been established in this domain, in the recent past.
A detailed analysis of various investments made by players engaged in this domain, during the period 2017-2021.
A detailed analysis of the current and future market based on blue ocean strategy, covering a strategic plan / guide for emerging players in this domain to help unlock an uncontested market.
Artificial Intelligence in Oncology market is dominated by companies based in North America; of these majority were established post 2010.
The report also features the likely distribution of the current and forecasted opportunity across important market segments, mentioned below:
Type of Cancer
Solid Malignancies
Breast Cancer
Lung Cancer
Prostate Cancer
Colorectal Cancer
Brain Tumor
Others
Type of End-User
Hospitals
Pharma Companies
Research Institutes
Others
Key Geographical Regions
North America
Europe
Asia Pacific
Rest of the World
Key Questions Answered
Who are the leading players engaged in the development of AI in oncology-based software solutions?
Which type of end-users are primarily employing AI in oncology-based software solutions in their regular workflow?
What kind of partnership models are most commonly being adopted by stakeholders engaged in this domain?
What is the trend for capital investments in this domain?
What are the key strategies that can be implemented by emerging players / start-ups to enter into this highly competitive market?
What is the focus area of big pharma players in this domain?
Which companies are actively filing patents to drive innovation in the field of AI in oncology?
What are the key challenges associated within this domain?
To view more details on this report, click on the link
https://www.rootsanalysis.com/....reports/ai-in-oncolo
You may also be interested in the following titles:
Non-Viral Transfection Reagents and Systems Market
Deep Learning in Drug Discovery Market and Deep Learning in Diagnostics Market
You may also like to learn what our experts are sharing in Roots educational series:
Genotoxicity Testing: Unlocking the Future Safety Assessment Opportunities
Adeno-Associated Viral Vectors: Unlocking the Future Opportunities
About Roots Analysis
Roots Analysis is a global leader in the pharma / biotech market research. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, venture capitalists and strategic investors for more than a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights.
Contact:
Ben Johnson
+1 (415) 800 3415
Ben.johnson@rootsanalysis.com
The “Artificial Intelligence in Oncology Market, 2022-2035” report features an extensive study on the current and future potential of AI.
Key Market Insights
A detailed overview of the overall market landscape of players engaged in the development of artificial intelligence in oncology- based software solutions.
Elaborate profiles of prominent players that specialize in offering artificial intelligence in oncology- based software solutions.
A competitiveness analysis of artificial intelligence in oncology- based software providers, based on supplier strength, portfolio diversity and portfolio strength.
An in-depth analysis of patents related to artificial intelligence in oncology- based software solutions, filed / granted till date.
An analysis of the partnerships that have been established in this domain, in the recent past.
A detailed analysis of various investments made by players engaged in this domain, during the period 2017-2021.
A detailed analysis of the current and future market based on blue ocean strategy, covering a strategic plan / guide for emerging players in this domain to help unlock an uncontested market.
Artificial Intelligence in Oncology market is dominated by companies based in North America; of these majority were established post 2010.
The report also features the likely distribution of the current and forecasted opportunity across important market segments, mentioned below:
Type of Cancer
Solid Malignancies
Breast Cancer
Lung Cancer
Prostate Cancer
Colorectal Cancer
Brain Tumor
Others
Type of End-User
Hospitals
Pharma Companies
Research Institutes
Others
Key Geographical Regions
North America
Europe
Asia Pacific
Rest of the World
Key Questions Answered
Who are the leading players engaged in the development of AI in oncology-based software solutions?
Which type of end-users are primarily employing AI in oncology-based software solutions in their regular workflow?
What kind of partnership models are most commonly being adopted by stakeholders engaged in this domain?
What is the trend for capital investments in this domain?
What are the key strategies that can be implemented by emerging players / start-ups to enter into this highly competitive market?
What is the focus area of big pharma players in this domain?
Which companies are actively filing patents to drive innovation in the field of AI in oncology?
What are the key challenges associated within this domain?
To view more details on this report, click on the link
https://www.rootsanalysis.com/....reports/ai-in-oncolo
You may also be interested in the following titles:
Non-Viral Transfection Reagents and Systems Market
Deep Learning in Drug Discovery Market and Deep Learning in Diagnostics Market
You may also like to learn what our experts are sharing in Roots educational series:
Genotoxicity Testing: Unlocking the Future Safety Assessment Opportunities
Adeno-Associated Viral Vectors: Unlocking the Future Opportunities
About Roots Analysis
Roots Analysis is a global leader in the pharma / biotech market research. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, venture capitalists and strategic investors for more than a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights.
Contact:
Ben Johnson
+1 (415) 800 3415
Ben.johnson@rootsanalysis.com
#artificialintelligenceinoncologymarkettrends #artificialintelligenceinoncologymarketshare #aiin cancer #oncologymarketresearch #aimedicaldiagnosticsTIL Therapies market 2022 – Industry Growth by 2035
Owing to their tumor-killing capability and therapeutic superiority to conventional therapies, TIL-based therapies are being actively evaluated to treat advance, incurable oncological disorders by various researchers and industry stakeholders
Roots Analysis is pleased to announce the publication of its recent study, titled, “Global TIL-based Therapy Market (2nd Edition), 2023-2035.”
The study features an in-depth analysis of key drivers and trends related to this domain. Amongst other elements, the report includes:
A detailed assessment of the current market landscape of TIL-based therapies.
A detailed analysis of completed, ongoing and planned clinical studies related to TIL-based therapies.
An insightful analysis highlighting the key opinion leaders (KOLs) in this domain featuring an analysis of the various principal investigators of clinical trials related to TIL-based therapies.
Elaborate profiles of mid- to late-stage clinical products (phase I/II or above).
An analysis of various type of partnership that have been inked between several stakeholders in the domain of TIL therapies.
An analysis of the investments that have been made into companies that have proprietary TIL-based products / technologies.
An in-depth analysis of patents related to TIL-based therapies, filed / granted till 2022.
A case study on manufacturing cell therapy products, highlighting the key challenges, and a detailed list of contract service providers and in-house manufacturers involved in this space.
An elaborate discussion on various factors that form the basis for the pricing of cell-based therapies.
Elaborate profiles of the several leading players in the domain of TCR cell therapies.
A detailed market forecast, featuring analysis of the current and projected future opportunity across key market segments (listed below):
Target Indication(s)
Melanoma
Head and Neck Carcinoma
Chronic Lymphocytic Leukemia
Sarcoma
Hepatocellular Carcinoma
Breast Cancer
Acute Myeloid Leukemia
Cervical Carcinoma
Key Geographical Regions
North America
Europe
Asia Pacific
Latin America
Middle East and North Africa
Rest of the World
The research includes profiles of key players (listed below); each profile features a brief overview of the company, details related to its financial information (if available), details about TIL-based product(s), such as information on status of development, technology portfolio (if available), recent developments related to TIL-based therapies and manufacturing capabilities of the players.
Cellectis
Cellular Biomedicine Group
Iovance Biotherapeutics
Lytix Biopharma
Phio Pharmaceuticals
To view more details on this report, click on the link
https://www.rootsanalysis.com/....reports/til-therapie
You may also be interested in the following titles:
Lab Automation Market
Cannabis Testing Market
You may also like to learn what our experts are sharing in Roots educational series:
Genotoxicity Testing: Unlocking the Future Safety Assessment Opportunities
Adeno-Associated Viral Vectors: Unlocking the Future Opportunities
About Roots Analysis
Roots Analysis is a global leader in the pharma / biotech market research. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, venture capitalists and strategic investors for more than a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights.
Contact:
Ben Johnson
+1 (415) 800 3415
Ben.johnson@rootsanalysis.com
#til-basedtherapies #tumorinfiltratinglymphocytereceptor #til #marketresearch #marketinsights
- Sponsored
Never Too Far Down, You Can't ..
We found a way when it seemed hopeless. We came back. We sho..
- Sponsored
Camera Competitions
Snap up some amazing images with this amazing photography bu..